Cardiology Department, APHM, La Timone Hospital, Boulevard Jean Moulin, Marseille, France.
Aix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
Eur Heart J Qual Care Clin Outcomes. 2019 Jul 1;5(3):202-207. doi: 10.1093/ehjqcco/qcz018.
The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) European Endocarditis (EURO-ENDO) registry aims to study the care and outcomes of patients diagnosed with infective endocarditis (IE) and compare findings with recommendations from the 2015 ESC Clinical Practice Guidelines for the management of IE and data from the 2001 Euro Heart Survey.
Patients (n = 3116) aged over 18 years with a diagnosis of IE based on the ESC 2015 IE diagnostic criteria were prospectively identified between 1 January 2016 and 31 March 2018. Individual patient data were collected across 156 centres and 40 countries. The primary endpoint is all-cause mortality in hospital and at 1 year. Secondary endpoints are 1-year morbidity (all-cause hospitalization, any cardiac surgery, and IE relapse), the clinical, epidemiological, microbiological, and therapeutic characteristics of patients, the number and timing of non-invasive imaging techniques, and adherence to recommendations as stated in the 2015 ESC Clinical Practice Guidelines for the management of IE.
EURO-ENDO is an international registry of care and outcomes of patients hospitalized with IE which will provide insights into the contemporary profile and management of patients with this challenging disease.
欧洲心脏病学会(ESC)欧洲观察性研究计划(EORP)欧洲心内膜炎(EURO-ENDO)注册旨在研究诊断为感染性心内膜炎(IE)患者的治疗和预后,并将研究结果与 2015 ESC 临床实践指南中关于 IE 的管理建议和 2001 年欧洲心脏调查的数据进行比较。
2016 年 1 月 1 日至 2018 年 3 月 31 日期间,前瞻性地确定了年龄在 18 岁以上、根据 ESC 2015 年 IE 诊断标准诊断为 IE 的患者(n=3116)。通过 156 个中心和 40 个国家收集了个体患者数据。主要终点是住院期间和 1 年时的全因死亡率。次要终点是 1 年时的发病率(全因住院、任何心脏手术和 IE 复发)、患者的临床、流行病学、微生物学和治疗特征、非侵入性影像学技术的数量和时机,以及对 2015 ESC 临床实践指南中关于 IE 管理建议的遵守情况。
EURO-ENDO 是一项关于住院治疗 IE 患者的护理和预后的国际注册,将深入了解当前患有这种挑战性疾病患者的概况和管理。